Haupt A - Search Results

1

Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis.

Mather KJ, Mari A, Weerakkody G, Heise T, DeVries JH, Urva S, Coskun T, Milicevic Z, Haupt A, Thomas MK. Mather KJ, et al. Among authors: haupt a. Diabetes Obes Metab. 2025 Jan 6. doi: 10.1111/dom.16159. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39762971

2

Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1-5 Clinical Trials.

Apperloo EM, Tuttle KR, Pavo I, Haupt A, Taylor R, Wiese RJ, Hemmingway A, Cherney DZI, Sattar N, Heerspink HJL. Apperloo EM, et al. Among authors: haupt a. Diabetes Care. 2025 Jan 2:dc241773. doi: 10.2337/dc24-1773. Online ahead of print. Diabetes Care. 2025. PMID: 39746157

3

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial.

Nicholls SJ, Ni W, Rhodes GM, Nissen SE, Navar AM, Michael LF, Haupt A, Krege JH. Nicholls SJ, et al. Among authors: haupt a. JAMA. 2025 Jan 21;333(3):222-231. doi: 10.1001/jama.2024.24017. JAMA. 2025. PMID: 39556768 Clinical Trial.

4

A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy.

Knop FK, Urva S, Rettiganti M, Benson CT, Roell WC, Mather KJ, Haupt A, Pratt EJ. Knop FK, et al. Among authors: haupt a. Diabetes Obes Metab. 2024 Nov;26(11):5474-5478. doi: 10.1111/dom.15875. Epub 2024 Aug 27. Diabetes Obes Metab. 2024. PMID: 39188238 No abstract available.

5

Oxytocin receptors in the nucleus accumbens shell are necessary for the onset of maternal behavior.

Witchey S, Haupt A, Caldwell HK. Witchey S, et al. Among authors: haupt a. Front Neurosci. 2024 Jul 2;18:1356448. doi: 10.3389/fnins.2024.1356448. eCollection 2024. Front Neurosci. 2024. PMID: 39015375 Free PMC article.

6

New improved radiometabolite analysis method for [¹⁸F]FTHA from human plasma: a test-retest study with postprandial and fasting state.

Aarnio R, Kirjavainen A, Rajander J, Forsback S, Kalliokoski K, Nuutila P, Milicevic Z, Coskun T, Haupt A, Laitinen I, Haaparanta-Solin M. Aarnio R, et al. Among authors: haupt a. EJNMMI Res. 2024 Jun 13;14(1):53. doi: 10.1186/s13550-024-01114-5. EJNMMI Res. 2024. PMID: 38869780 Free PMC article.

7

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

Sanyal AJ, Kaplan LM, Frias JP, Brouwers B, Wu Q, Thomas MK, Harris C, Schloot NC, Du Y, Mather KJ, Haupt A, Hartman ML. Sanyal AJ, et al. Among authors: haupt a. Nat Med. 2024 Jul;30(7):2037-2048. doi: 10.1038/s41591-024-03018-2. Epub 2024 Jun 10. Nat Med. 2024. PMID: 38858523 Free PMC article. Clinical Trial.

8

Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.

Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ; SYNERGY-NASH Investigators. Loomba R, et al. Among authors: haupt a. N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8. N Engl J Med. 2024. PMID: 38856224 Clinical Trial.

9

Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.

Mather KJ, Mari A, Heise T, DeVries JH, Hua M, Urva S, Coskun T, Haupt A, Heine RJ, Pratt E, Thomas MK, Milicevic Z. Mather KJ, et al. Among authors: haupt a. J Clin Endocrinol Metab. 2024 Nov 18;109(12):3046-3054. doi: 10.1210/clinem/dgae319. J Clin Endocrinol Metab. 2024. PMID: 38795393 Clinical Trial.

10

Volenrelaxin (LY3540378) increases renal plasma flow: a randomized Phase 1 trial.

Tham LS, Heerspink HJL, Wang X, Verdino P, Saifan CG, Benson EA, Goldsmith P, Wang Z, Testani JM, Haupt A, Sam F, Cherney DZI. Tham LS, et al. Among authors: haupt a. Nephrol Dial Transplant. 2024 Dec 20;40(1):109-122. doi: 10.1093/ndt/gfae112. Nephrol Dial Transplant. 2024. PMID: 38782726 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters